BioSenic S.A. (0R55.L)

LSE • Currency in EUR

€0.00

-8.33%

Last Update: 17 Jul 2025, 16:23

€1.44M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

€0.00 - €0.19

52 Week Range

0R55.L Stock Price Chart

Explore BioSenic S.A. interactive price chart. Choose custom timeframes to analyze 0R55.L price movements and trends.

There is nothing to show.

0R55.L Company Profile

Discover essential business fundamentals and corporate details for BioSenic S.A. (0R55.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

26 Oct 2022

Employees

12.00

Website

https://www.biosenic.com

CEO

Alexia Rieger

Description

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.

0R55.L Financial Timeline

Browse a chronological timeline of BioSenic S.A. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 29 May 2025

Earnings released on 30 Sept 2024

EPS came in at €0.00, while revenue for the quarter reached €2.69M.

Earnings released on 27 May 2024

EPS came in at -€0.05, while revenue for the quarter reached €178.00K.

Earnings released on 29 Jun 2023

EPS came in at -€0.17, while revenue for the quarter reached €182.50K.

Earnings released on 31 Dec 2022

EPS came in at -€0.01, while revenue for the quarter reached €141.00K.

Earnings released on 29 Jun 2022

EPS came in at -€0.15.

Dividend declared on 15 Mar 2022

A dividend of €0.29 per share was announced, adjusted to €0.29.

Earnings released on 30 Dec 2021

EPS came in at -€0.40, while revenue for the quarter reached €1.00M.

Earnings released on 29 Jun 2021

EPS came in at -€0.37.

Earnings released on 30 Dec 2020

EPS came in at -€0.14, while revenue for the quarter reached €1.00M.

0R55.L Stock Performance

Access detailed 0R55.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.